???pagination.result.count???
???pagination.result.page???
1
From zebrafish to human: A comparative approach to elucidate the role of the thyroid hormone transporter MCT8 during brain development. , Vancamp P., Gen Comp Endocrinol. September 1, 2018; 265 219-229.
The molecular mechanism of intestinal levodopa absorption and its possible implications for the treatment of Parkinson's disease. , Camargo SM., J Pharmacol Exp Ther. October 1, 2014; 351 (1): 114-23.
Exon capture and bulk segregant analysis: rapid discovery of causative mutations using high-throughput sequencing. , del Viso F., BMC Genomics. November 21, 2012; 13 649.
Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2. , del Amo EM., Eur J Pharm Sci. October 2, 2008; 35 (3): 161-74.
Reabsorption of neutral amino acids mediated by amino acid transporter LAT2 and TAT1 in the basolateral membrane of proximal tubule. , Park SY., Arch Pharm Res. April 1, 2005; 28 (4): 421-32.
Asymmetry of glutamine transporters in cultured neural cells. , Heckel T., Neurochem Int. January 1, 2003; 43 (4-5): 289-98.
Transport of a neurotoxicant by molecular mimicry: the methylmercury-L-cysteine complex is a substrate for human L-type large neutral amino acid transporter (LAT) 1 and LAT2. , Simmons-Willis TA., Biochem J. October 1, 2002; 367 (Pt 1): 239-46.
Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells. , Kim DK., Biochim Biophys Acta. September 20, 2002; 1565 (1): 112-21.
Identification and characterization of a Na(+)-independent neutral amino acid transporter that associates with the 4F2 heavy chain and exhibits substrate selectivity for small neutral D- and L-amino acids. , Fukasawa Y., J Biol Chem. March 31, 2000; 275 (13): 9690-8.
[Amino acid transporter molecule as a drug target]. , Endou H., Nihon Yakurigaku Zasshi. October 1, 1999; 114 Suppl 1 11P-16P.